List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 42 studies with search of:   "Lomustine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients
Conditions: Brain Neoplasms;   Melanoma
Interventions: Drug: Lomustine;   Drug: Temozolomide;   Drug: Thalidomide
2 Active, not recruiting Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour
Conditions: Recurrent Glioblastoma;   Brain Tumor
Interventions: Drug: Cediranib;   Drug: Lomustine
3 Completed Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
Condition: Glioblastoma
Interventions: Drug: Edotecarin;   Drug: Temozolomide;   Drug: Carmustine (BCNU);   Drug: Lomustine (CCNU)
4 Recruiting Adding Lomustine to Chemotherapy in Older Patients With Acute Myelogenous Leukemia (AML), and Allogeneic Transplantation for Patients From 60 to 65 Years Old
Condition: Acute Myeloid Leukemia
Intervention: Drug: Lomustine
5 Completed Lomustine and Intermediate Dose Cytarabine in Older Patients With AML
Condition: Acute Myeloid Leukemia
Intervention: Drug: Lomustine, intermediate dose cytarabine
6 Active, not recruiting Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Drug: lomustine
7 Recruiting 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients
Conditions: Anaplastic Glioma;   Glioblastoma Multiforme;   Brain Cancer
Interventions: Drug: Capecitabine;   Drug: Celecoxib;   Drug: Temozolomide;   Drug: Lomustine;   Drug: 6-Thioguanine
8 Recruiting Phase III: Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma.
Condition: Recurrent Glioblastoma
Interventions: Drug: Cediranib;   Drug: Cediranib;   Drug: Lomustine Chemotherapy
9 Active, not recruiting Enzastaurin Versus Lomustine in Glioblastoma
Condition: Glioblastoma
Interventions: Drug: enzastaurin;   Drug: lomustine
10 Active, not recruiting Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Drug: lomustine;   Drug: temozolomide;   Drug: thalidomide
11 Active, not recruiting Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: lomustine;   Drug: temozolomide;   Procedure: adjuvant therapy;   Procedure: radiation therapy
12 Active, not recruiting Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: lomustine;   Drug: temozolomide
13 Active, not recruiting Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma
Condition: Lymphoma
Interventions: Drug: cytarabine;   Drug: dexamethasone;   Drug: lomustine;   Drug: methotrexate;   Drug: procarbazine hydrochloride
14 Recruiting Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: lomustine;   Drug: procarbazine hydrochloride;   Drug: temozolomide;   Drug: vincristine sulfate
15 Active, not recruiting Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: lomustine;   Drug: procarbazine hydrochloride;   Drug: vincristine sulfate;   Procedure: radiation therapy
16 Active, not recruiting Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: cyclophosphamide;   Drug: dexamethasone;   Drug: idarubicin;   Drug: lomustine;   Drug: melphalan;   Drug: prednisolone
17 Recruiting Radiation Therapy Followed By Combination Chemotherapy in Treating Young Patients With Supratentorial Primitive Neuroectodermal Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cisplatin;   Drug: lomustine;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Procedure: radiation therapy
18 Recruiting Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cisplatin;   Drug: lomustine;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Procedure: radiation therapy
19 Completed Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cisplatin;   Drug: cyclophosphamide;   Drug: filgrastim;   Drug: lomustine;   Drug: mesna;   Drug: vincristine sulfate;   Procedure: low-LET electron therapy;   Procedure: low-LET photon therapy
20 Active, not recruiting Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors
Conditions: Brain and Central Nervous System Tumors;   Cancer-Related Problem/Condition
Interventions: Drug: filgrastim;   Drug: lomustine;   Drug: procarbazine hydrochloride;   Drug: vincristine sulfate;   Procedure: conventional surgery;   Procedure: gene therapy;   Procedure: in vitro-treated peripheral blood stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options